Toth Christopher A.
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Toth Christopher A.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| BAX | EVP, Group Pres, Kidney Care | Tax Withholding | 25,372 | $32.56 | $826,112 | Jan 31, 2025 |
| BAX | EVP,Group Pres, Kidney Care | Tax Withholding | 32,610 | $29.16 | $950,908 | Dec 31, 2024 |
| BAX | EVP,Group Pres, Kidney Care | Tax Withholding | 15,202 | $34.08 | $518,084 | Jun 3, 2024 |
| BAX | EVP,Group Pres, Kidney Care | Award / Grant | 119,076 | — | — | Mar 6, 2024 |
| BAX | EVP, Group Pres, Kidney Care | Award / Grant | 106,358 | — | — | Jun 1, 2023 |
| 0000203527 | SVP and Pres. Oncology Systems | Disposition | 15,418 | — | — | Apr 15, 2021 |
| 0000203527 | SVP and Pres. Oncology Systems | Tax Withholding | 848 | $176.15 | $149,375 | Feb 16, 2021 |
| 0000203527 | SVP and Pres. Oncology Systems | Option Exercise | 8,794 | $112.82 | $992,139 | Dec 1, 2020 |
| 0000203527 | SVP and Pres. Oncology Systems | Tax Withholding | 667 | $173.50 | $115,725 | Nov 23, 2020 |
| 0000203527 | SVP and Pres. Oncology Systems | Sale | 996 | $109.33 | $108,893 | Apr 13, 2020 |
| 0000203527 | SVP and Pres. Oncology Systems | Option Exercise | 632 | — | — | Feb 18, 2020 |
| 0000203527 | SVP and Pres. Oncology Systems | Option Exercise | 1,597 | $112.82 | $180,174 | Jan 3, 2020 |
| 0000203527 | SVP and Pres. Oncology Systems | Sale | 419 | $138.80 | $58,157 | Dec 6, 2019 |
| 0000203527 | SVP and Pres. Oncology Systems | Tax Withholding | 719 | $129.97 | $93,448 | Nov 21, 2019 |
| 0000203527 | SVP and Pres. Oncology Systems | Option Exercise | 1,400 | $112.82 | $157,948 | Apr 1, 2019 |
| 0000203527 | SVP and Pres. Oncology Systems | Sale | 1,211 | $137.50 | $166,513 | Mar 22, 2019 |
| 0000203527 | SVP and Pres. Oncology Systems | Sale | 400 | $136.19 | $54,476 | Mar 18, 2019 |
| 0000203527 | SVP and Pres. Oncology Systems | Option Exercise | 1,656 | — | — | Feb 15, 2019 |